Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary L Faber

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMC Research Notes|December 16, 2014
Characterization of the developing small intestine in the absence of either GATA4 or GATA6Emily M Walker, Cayla A Thompson, Bridget M Kohlnhofer, et al.
Biomolecules|February 25, 2023
Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic InterventionsAnnie Kleynerman, Jitka Rybova, Mary L Faber, et al.
Developmental Biology|July 7, 2012
E-cadherin is required for intestinal morphogenesis in the mouseBenjamin J Bondow, Mary L Faber, Kevin J Wojta, et al.
Experimental and Molecular Pathology|May 10, 2024
Fate control engagement augments NK cell responses in LV/hu-IL-12 transduced sarcomaMary Jo Rademacher, Mary L Faber, Kathleen M Bone, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 2, 2022
Pathophysiological characterization of the Townes mouse model for sickle cell diseaseJuliana Alvarez-Argote, Theresa A Dlugi, Teresa Sundararajan, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 12, 2024
Cardiac dysfunction and altered gene expression in acid ceramidase-deficient miceAnnie Kleynerman, Jitka Rybova, William M McKillop, et al.
The Journal of Gene Medicine|July 17, 2023
A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease miceXuejun Wang, William M McKillop, Theresa A Dlugi, et al.
Journal for Immunotherapy of Cancer|August 11, 2020
Discovery and validation of surface <i>N</i>-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targetsRobyn A A Oldham, Mary L Faber, Theodore R Keppel, et al.
EMBO Molecular Medicine|March 17, 2022
Autologous, lentivirus-modified, T-rapa cell "micropharmacies" for lysosomal storage disordersMurtaza S Nagree, Tania C Felizardo, Mary L Faber, et al.
Frontiers in Immunology|August 30, 2023
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activityMary L Faber, Robyn A A Oldham, Archana Thakur, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMC Research Notes|December 16, 2014
Characterization of the developing small intestine in the absence of either GATA4 or GATA6Emily M Walker, Cayla A Thompson, Bridget M Kohlnhofer, et al.
Biomolecules|February 25, 2023
Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic InterventionsAnnie Kleynerman, Jitka Rybova, Mary L Faber, et al.
Developmental Biology|July 7, 2012
E-cadherin is required for intestinal morphogenesis in the mouseBenjamin J Bondow, Mary L Faber, Kevin J Wojta, et al.
Experimental and Molecular Pathology|May 10, 2024
Fate control engagement augments NK cell responses in LV/hu-IL-12 transduced sarcomaMary Jo Rademacher, Mary L Faber, Kathleen M Bone, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 2, 2022
Pathophysiological characterization of the Townes mouse model for sickle cell diseaseJuliana Alvarez-Argote, Theresa A Dlugi, Teresa Sundararajan, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 12, 2024
Cardiac dysfunction and altered gene expression in acid ceramidase-deficient miceAnnie Kleynerman, Jitka Rybova, William M McKillop, et al.
The Journal of Gene Medicine|July 17, 2023
A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease miceXuejun Wang, William M McKillop, Theresa A Dlugi, et al.
Journal for Immunotherapy of Cancer|August 11, 2020
Discovery and validation of surface <i>N</i>-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targetsRobyn A A Oldham, Mary L Faber, Theodore R Keppel, et al.
EMBO Molecular Medicine|March 17, 2022
Autologous, lentivirus-modified, T-rapa cell "micropharmacies" for lysosomal storage disordersMurtaza S Nagree, Tania C Felizardo, Mary L Faber, et al.
Frontiers in Immunology|August 30, 2023
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activityMary L Faber, Robyn A A Oldham, Archana Thakur, et al.
Pageof 1